Hotline:
+ 49 (0) 2204 2918806

Market studies for category X

Items 1 to 10 of 16 total

  1. Net price*
    Year
  2. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Xoft Inc. - Medical Equipment - Deals and Alliances Profile

    GlobalData
    24 Pages
    Xoft Inc. (Xoft) is a medical device company. The company develops brachytherapy systems using its miniaturized X-ray tube technology to apply a therapeutic dose of isotope-free radiation to a tumor target. Its products include axxent controller, HDR X-ray source, axxent applicators and other axxent accessories such as physics kit, rigid
    Englisch | Zukunftsanalyse | SKU: 159281
  3. $750.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    XAir Diagnostics B.V. - Product Pipeline Analysis.

    GlobalData
    17 pages
    XAir Diagnostics B.V. (XAir) develops diagnostics based on the exhaled breath for diseases with large unmet diagnostic needs. The company is developing diagnostic products and services with clear benefits to patients and physicians, by analysing the exhaledbreath of patients. XAir developed a proprietary discovery platform XVOC whioch all
    Englisch | | SKU: 329470
  4. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Xcelience, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    17 pages
    Xcelience, LLC (Xcelience) is a pharmaceutical company. The company provides formulation development and manufacturing solutions. Its services include formulation development, preformulation, analytical method development, validation and stability, GMP manufacturing, packaging and labeling, clinical packaging and chemistry playbook. The c
    Englisch | Zukunftsanalyse | SKU: 331911
  5. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Xceleron Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    16 pages
    Xceleron Inc (Xceleron) is a pharmaceutical service provider. The company provides analytical solutions for drug development programs. It uses accelerator mass spectrometry (AMS) technology delivers solutions. The company provides services such as pharmaceutical and biobased services. Xceleron’s technology support preclinical analysis f
    Englisch | Zukunftsanalyse | SKU: 359780
  6. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    XDx, Inc. - Medical Equipment - Deals and Alliances Profile

    GlobalData
    31 pages
    XDx, Inc. (XDx) is a biotechnology company. The company develops molecular diagnostic assays that translate a patient's immune status into clinically actionable information. It discovers gene expression testing for the monitoring of transplant rejection and autoimmune diseases. Gene expression patterns reflect the activity of genes in the
    Englisch | Zukunftsanalyse | SKU: 262471
  7. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    XERIS Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    17 pages
    XERIS Pharmaceuticals, Inc. (XERIS) is a biopharmaceutical company. The company develops injectables for the treatment of diabetes, epilepsy, and immunology. Its products include xerisol glucagon and xeriject diazepam. XERIS’s proprietary delivery system offers several advantages over existing needle and needle-free formulations which i
    Englisch | Zukunftsanalyse | SKU: 331904
  8. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Xention Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    18 pages
    Xention Limited (Xention) formerly Xention Discovery Ltd. is a biopharmaceutical company. The company discovers and develops ion channel-modulating drugs. Its products include XEN-D0103 and ikach. Xention uses its technology to develop a portfolio of drug candidates in the area of atrial fibrillation. The company product includes drug can
    Englisch | Zukunftsanalyse | SKU: 338881
  9. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Xenetic Biosciences plc (XEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    55 pages
    Xenetic Biosciences plc (Xenetic) is a bio-pharmaceutical company. It carries out the development of drugs for cancer therapies and vaccines. The company has developed proprietary patented technologies to create a new generation drug and vaccine products such as PolyXen for protein drug delivery, ImuXen for vaccine delivery and Oncohist.
    Englisch | Zukunftsanalyse | SKU: 163506
  10. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Xanodyne Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    24 pages
    Xanodyne Pharmaceuticals, Inc. (Xanodyne) is a pharmaceutical company. It undertakes the development, production and commercialization of pain management and women's healthcare products. Its products include roxicodone, XP12B and XP20B. Xanodyne also develops product candidates through the application of proprietary drug delivery and form
    Englisch | Zukunftsanalyse | SKU: 331879
  11. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Xenon Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    19 pages
    Xenon Pharmaceuticals Inc. (Xenon) is a genetics-based drug discovery and development company. It carries out the development of innovative therapeutics for unmet medical needs including pain, anemia, metabolic, and cardiovascular disease. The company develops drugs based on clinically and genetically validated drug targets. The product p
    Englisch | Zukunftsanalyse | SKU: 338872

Items 1 to 10 of 16 total